BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

A new poll finds most Americans say they've used artificial intelligence to search for information. But it's younger adults ...

A number of the executive orders and announcements coming from the White House since Donald Trump returned to office have ...

Quantum computing has advanced significantly by 2025, with several systems pushing the limits of computational power through ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

A groundbreaking new medical dataset is poised to revolutionize health care in Africa by improving chatbots' understanding of ...

The world’s biggest crude producer is partnering with SandboxAQ to turn captured carbon into profitable products.

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...

Broadly speaking, opportunity risk can be thought of as “the potential loss or missed opportunity that an organization faces ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

President Donald Trump’s plan to boost artificial intelligence and build data centers across the U.S. could speed up a building boom that was already expected to strain the nation’s ability ...

Each year, the World Economic Forum (WEF) releases its Technology Pioneers list – a curated collection of companies that are ...